Suicide Is Surprise In FDA Review Of Lupus Drug - Matthew Herper - The Medicine Show - Forbes
Links shared publicly online about this topic.
- 732total visits
Suicide Is Surprise In FDA Review Of Lupus Drug - Matthew Herper - The Medicine Show - Forbes
The Food and Drug Administration released its review of the data supporting the approval of Benlysta, the lupus treatment being developed by Human Genome Sciences and GlaxoSmithKline, this morning. The FDA's briefing documents will serve as the basis for a discussion by a panel of experts on November 16. Analysts [...]
View full resource at blogs.forbes.com
Tags: Suicide, Lupus, Drug, FDA, GlaxoSmithKline, Science
Most Recently Shared on November 12, 2010 at 4:28 pm By:
Suicide Is Surprise In FDA Review Of Lupus Drug: A new worry crops up for a promising drug. http://bit.ly/bMsimC #drug
Advertisement
